MENU
KURE
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

KURE stock forecast, quote, news & analysis

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for KURE with price predictions
Nov 09, 2026

KURE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for KURE turned positive on November 04, 2026. Looking at past instances where KURE's MACD turned positive, the stock continued to rise in 37 of 43 cases over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on KURE as a result. In 66 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

KURE moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where KURE advanced for three days, in 224 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for KURE crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

KURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for KURE entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Industry description

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index. The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.

Market Cap

The average market capitalization across the KraneShares MSCI All China Health Care Index ETF (KURE) ETF is 7.45B. The market cap for tickers in the group ranges from 4.55B to 4.55B. LEGN holds the highest valuation in this group at 4.55B. The lowest valued company is LEGN at 4.55B.

High and low price notable news

The average weekly price growth across all stocks in the KraneShares MSCI All China Health Care Index ETF (KURE) ETF was -2%. For the same ETF, the average monthly price growth was 13%, and the average quarterly price growth was -26%. LEGN experienced the highest price growth at 15%, while LEGN experienced the biggest fall at 15%.

Volume

The average weekly volume growth across all stocks in the KraneShares MSCI All China Health Care Index ETF (KURE) ETF was -11%. For the same stocks of the ETF, the average monthly volume growth was 24% and the average quarterly volume growth was 13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 93
Price Growth Rating: 67
SMR Rating: 89
Profit Risk Rating: 96
Seasonality Score: -37 (-100 ... +100)